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Early Experience with the Minimal Extracorporeal
Circulation System (MECCw) During Thoracoabdominal
Aortic Aneurysm Repair
D. Palombo,* D. Valenti, A. Gaggiano, M. Lupo and P. Borin
Department of Cardiac and Vascular Diseases, Vascular Surgery Unit, Mauriziano Hospital, Largo Turati, 62,
Turin I-10128, Italy
Aim. The purpose of this report is to describe our early experience with a minimal extracorporeal circulation system
(MECC), a compact closed heparin coated system consisting of a centrifugal pump and a membrane oxygenator, during
thoracoabdominal aortic aneurysm (TAAA) repair.
Methods. Between January and December 2002 the MECC system was employed in seven consecutive patients (four TAAA
type II, two TAAA type I and one TAAA type III according to the Crawford classification). In all patients distal aortic,
selective renal and visceral perfusion was performed with this compact closed heparin coated system consisting of a
centrifugal pump and a membrane oxygenator.
Results. The MECC system was used in all cases with no technical malfunctions. Six out seven patients were discharged
from the unit. One patient developed paraplegia after TAAA repair and died on the third post-operative day from multi-
organ failure. In this case the total spinal ischaemic time was 120 min and the distal aortic perfusion pressure was
,50 mmHg. No cardiac, cerebral, renal, hepatic or bleeding complications were recorded in the remaining six patients.
Conclusion. Our early experience with MECC during TAAA repair showed that it is feasible for distal aortic spinal and
visceral selective perfusion. Further large clinical trials are required to determine the efficacy of this technique.
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Introduction
Paraplegia and paraparesis, visceral and renal ische-
mia are the most serious complications after repair of
extensive TAAA.1 Distal aortic perfusion by atrio-
distal bypass (ADB) with the Bio-Medicusw pump
seems to play an important role in the prevention of
these complications.2
The minimal extracorporeal circulation system
(Jostra MECC systemw, Medizintechnik AG Germany)
is a compact closed heparin coated system consisting
of a centrifugal pump and a membrane oxygenator. A
recent report3 advocates the application of the MECC
system for circulatory support in beating heart surgery
with encouraging results. The use of this pump for
distal aortic perfusion during TAAA repair has not yet
been reported.
The aim of this paper is to describe our early
experience with the MECC system during TAAA
repair.
Materials and Methods
Between January and December 2002 the MECCw
system was employed for distal aortic perfusion
during TAAA repair in seven consecutive patients.
The median age was 68 (range: 64–71) years. There
were five males and two female patients. According to
the Crawford classification4 four patients had type II
TAAAs, two had type I TAAAs and one had a type III
TAAA. Six had hypertension, two had type II diabetes,
two had coronary artery disease (CAD) and one had a
pre-vertebral left subclavian aneurysm. The two
patients with CAD had had coronary angioplasty
with stenting prior to TAAA repair. The patient with a
pre-vertebral subclavian aneurysm underwent a sub-
clavian aneurysm resection and left subclavian artery
transposition to the left common carotid artery prior to
TAAA repair.
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The MECCw is a compact closed heparin coated
system consisting of a centrifugal pumphead (Rota-
flow RF-32 Jostra Medizintechnik AG Germany) and a
membrane oxygenator (Quadrox BE2814 Jostra Med-
izintechnik AG Germany). The length of the circuit
between arterial (20 F) and venous cannula (18–24 F)
is less than 100 cm. The pump is a centrifugal pump
with a surface area of 0.019 m and a priming volume of
32 ml. The membrane oxygenator (Quadrox BE2814
Jostra Medizintechnik AG Germany) has a surface
area for gas exchange of 1.8 m and a priming volume
of 250 ml with a blood flow rate of 0.5–7 l/min. The
arterial filter (Quart Jostra Medizintechnik AG
Germany) has a surface area of 0.057 m and a priming
volume of 180 ml; both are incorporated in the circuit.
The entire circuit surface is coated with heparin
(Bioline Coatingw Jostra Medizintechnik AG
Germany). The total priming volume was 400–500 ml.
The surgical technique used has been modified
from Coselli et al.5 A standard thoraco-abdominal
incision was used. The arterial cannula (20 F) was
inserted into the left common femoral artery and the
venous cannula (18–24 F) was inserted into the left
common femoral vein over a Terumow superstiff
guidewire in order to avoid any venous damage and
to facilitate the venous cannula progression into the
right atrium (Fig. 1).
After systemic heparinization (150 unit/kg) an
activated clotting time of 350 s was achieved. Follow-
ing thoracic cross clamping retrograde perfusion with
MECC system was started. The flow rate was adjusted
to maintain a distal aortic perfusion pressure of
80 mmHg and pulmonary artery pressure of
20 mmHg. These parameters were achieved at flow
rates of between 1200 and 2500 ml/min. The flow rate
to the visceral arteries,using a 9 –12 F coronary
perfusion cannula, was 700 ml/min. The proximal
anastomosis was performed end-to-end using a
woven Dacron graft. The distal clamp was then
repositioned to just above the visceral arteries and
the major intercostal arteries reattached to the graft in
the excluded aortic segment. The TAAA was then fully
opened and visceral and renal arteries selectively
perfused with visceral perfusion balloon catheters.
The major lower intercostal, visceral and renal arteries
were reattached to the graft using the standard
technique. After the reattachment of visceral and
renal arteries, the proximal clamp was removed in
order to re-establish antegrade perfusion during the
completion of the distal anastomosis. Sodium nitro-
prusside was not required to control the proximal
arterial pressure.
Cerebrospinal fluid drainage (CSFD) was routinely
performed and continued until the 2nd post-operative
day.
Fig. 1. MECC system circuit.
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Results
All seven patients underwent MECCw system distal
aortic perfusion without mechanical malfunction or
haemodynamic adverse events related to the system.
One patient with type II TAAA developed post-
operative paraplegia and died on the third post-
operative day from multiorgan failure. None of the
remaining patients had paraplegia, paraparesis, cer-
ebral, cardiac, visceral and renal ischaemic compli-
cations or coagulopathy. Post-operative renal function
was in the normal range and no bleeding compli-
cations occurred in the remaining six patients.
The mean total aortic clamp time was 57 min; in the
patient who developed paraplegia the crossclamp
time was 120 min. The mean flow rate for distal aortic
perfusion and selective visceral perfusion were 2.5 and
700 ml/min, respectively. The distal aortic perfusion
pressure was .80 mmHg in all cases except in the
patient who developed paraplegia in whom the distal
aortic perfusion pressure never exceeded 50 mmHg.
Discussion
Recent reports2 support the use of ADB with centrifu-
gal pump (Bio-Medicus) for aortic distal perfusion
during extensive TAAA repair. This technique brings
the advantage of lower priming volume, reduction of
haemolysis and decreased risk of air embolism.
Safi et al.1 employing this centrifugal pump in
conjunction with CSFD during type I and II TAAA
repair, showed a reduction of neurological deficits
compared to the control group (9% vs. 31% p ¼ 0:0034).
The MECC system used in our study was a compact
closed heparin coated system consisting of a centrifu-
gal pumphead with a priming volume of 32 ml (vs.
80 ml Bio-Medicus) and a membrane oxygenator.
Compared to the standard CPB, the MECC system
does not have left ventricular drainage, cardiotomy
suction and a venous reservoir. The main advantage of
the MECC system is the reduction of the blood surface
contact area due to a shorter cannula circuit (priming
volume of 450 ml). The entire system is heparin
coated, so it requires only moderate systemic hepar-
inization (150 units/kg) compared to CPB.
There are two potential drawbacks of this technique.
Firstly, there could be a risk of iliac vein and inferior vena
cava injury at the time of the insertion and progression of
the cannula even with the use of a guidewire. Secondly,
the system could not provide adequate retrograde
perfusion due to blood pressure instability.
The MECC system pump generates a pressure which
is related to the pump speed but the flow rate depends
mainly on the preload and the peripheral resistance. In
our experience the visceral perfusion was performed
with a 9–12 F coronary perfusion cannula and the flow
rate was only 700 ml/min even at maximum pump
speed. Doubtless, by increasing the size of the cannulae,
visceral perfusion could be improved but in our series,
we were forced to employ this catheter size because of
the anatomical size of the visceral arteries.
The MECC system at the present time is mostly
employed for circulatory support in beating heart
surgery.3 Our decision to apply this technique for
distal aortic perfusion during TAAA repair, was based
on the fact that it requires femoral vessel exposure
instead of left inferior pulmonary vein cannulation as
in the case of ADB. In fact in most European vascular
units, pulmonary vein cannulation is performed by a
cardiothoracic surgeon and not by a vascular surgeon.
Our initial experience with the MECC system
showed good distal aortic perfusion in all but one
case. In this case the distal aortic perfusion pressure
was ,50 mmHg due to proximal blood pressure
instability prevented an increase in distal blood flow.
In conclusion, the MECC system could be a useful
alternative to ADB for renal, visceral and spinal cord
protection during TAAA repair, especially in units in
which a cardiothoracic surgeon is not available. This
technique, in our early experience, is safe, effective and
relatively simple to carry out compared to conven-
tional CPB. A large prospective randomized trial
comparing the MECC system to the other accepted
extracorporeal techniques is needed in order to prove
its safety and efficacy.
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